GE closes $860m Vital Signs takeover
This article was originally published in Clinica
Executive Summary
UK-based medtech giant GE Healthcare has finalised its acquisition of medical device manufacturer Vital Signs in an $860m takeover. The deal, which was first announced in July (see Clinica No 1317, p 2), provides GE with Vital Signs’ portfolio of single-patient use products used in anaesthesia, respiratory, sleep therapy and emergency medicine procedures. According to GE, this acquisition will allow it to offer its customers “significant cost advantages and improved patient care features, including reducing the likelihood of transmitting infections from one patient to another”. Vital Signs (Totowa, New Jersey) will be incorporated into GE’s Clinical Systems business.